You're viewing a public preview of Orbus Therapeutics, Inc. Sign up free to access full investment history, financials, executives & more
Sign Up Free Log In

Orbus Therapeutics, Inc.

Active
2479 E. Bayshore Road, Suite 105,  Palo Alto,  California (CA),  94303,  United States
(650) 656-9440
Sector: Life Science Entity: Private Founded: 2012
2012
Founded
Year established
2
Transactions
Sign up to view
About Orbus Therapeutics, Inc.
Orbus Therapeutics, Inc. is a privately held biopharmaceutical company focused on developing treatments for rare diseases with limited therapeutic options, particularly malignant brain tumors. Founded in 2012, the company’s lead product candidate is oral eflornithine, which has been investigated in combination with lomustine for patients with recurrent anaplastic astrocytoma, a type of brain cancer. Orbus completed its Phase 3 STELLAR clinical study in 2024 and subsequently reported results showing clinically meaningful improvements in overall and progression-free survival in a subgroup of patients with recurrent IDH-mutant grade 3 astrocytoma. The company’s activities include clinical development, regulatory strategy, and commercialization planning for rare-disease therapies
Investors
Current Investors
US WorldMeds LLC ••••••••
Past Investors
•••••••• ••••••••
View Full Investor List
Sign up to see all current & past investors with deal dates and transaction details
Sign Up Free Log In
Investment Details
2 Transactions
Trans. IDInvestment DateExit DateInvestor(s)Deal Size (M)Seller(s)
Access 2 Transactions
Sign up to view the full investment history — dates, deal sizes, investors & sellers
Sign Up Free Log In
Orbus Therapeutics, Inc. M&A Activity
# Company Transaction Date Close Date Sector Country
View M&A Acquisitions
Sign up to explore the full acquisition & merger history
Sign Up Free Log In
Key Executives & Professionals
View Executives & Professionals
Sign up to access board members, senior management & key contacts
Sign Up Free Log In
Frequently Asked Questions
What does Orbus Therapeutics, Inc. do?
Orbus Therapeutics, Inc. is a privately held biopharmaceutical company focused on developing treatments for rare diseases with limited therapeutic options, particularly malignant brain tumors. Founded in 2012, the company’s lead product candidate is oral eflornithine, which has been investigated i
Where is Orbus Therapeutics, Inc. headquartered?
Orbus Therapeutics, Inc. is headquartered in Palo Alto, California (CA), United States.
When was Orbus Therapeutics, Inc. founded?
Orbus Therapeutics, Inc. was founded in 2012.
What sector is Orbus Therapeutics, Inc. in?
Orbus Therapeutics, Inc. operates in the Life Science sector.
Who are the investors in Orbus Therapeutics, Inc.?
Current investors in Orbus Therapeutics, Inc. include US WorldMeds LLC. Sign up to AcquityData to view full investor details, deal dates and transaction history.
How many M&A transactions has Orbus Therapeutics, Inc. been involved in?
Orbus Therapeutics, Inc. has 2 transactions tracked on AcquityData. Sign up to view full investment history including dates, deal sizes, investors and sellers.

Unlock the full Orbus Therapeutics, Inc. profile

Ownership & Investors M&A History Financials Key Executives Advisors & Lenders

Access Orbus Therapeutics, Inc.'s complete ownership history, M&A activity, investors, advisors and executives in one connected platform.

Start Free Trial